News

• 

   24.04.2026

  20 Years of TBnet: Two decades of unparalleled cross-border collaboration in tuberculosis research and education

  Tuberculosis is the leading cause of death by a single micro-organism. On April 21^st 2026, leading tuberculosis researchers from across Europe and beyond gathered at the Max von Pettenkofer Institute in Munich to celebrate the 20th anniversary of the Tuberculosis Network European Trials group (TBnet), marking two decades of sustained scientific collaboration, innovation, and education in the fight against tuberculosis. T

• 

   14.04.2026

  Long-term cure rates for multidrug-resistant tuberculosis much better than expected

  A new national cohort study from Latvia, conducted in collaboration with researchers from the clinical tuberculosis infrastructure (ClinTB) at the German Centre for Infection Research (DZIF) at the Research Centre Borstel, Leibniz Lung Centre (FZB), provides important insights into the treatment of multidrug-resistant tuberculosis (MDR-TB).

• 

   10.04.2026

  Borsteler Forscherin für ihre Arbeit zu Weizenallergenen ausgezeichnet
  

  Dr. Eva-Maria Rick aus der Forschungsgruppe „Klinische und Molekulare Allergologie“ (Ltg. Prof. U. Jappe) ist auf der Wissenschaftlichen Frühjahrstagung der DGAKI 2026, die vom 27.–28. März in Mainz stattfand, mit einem Abstractpreis ausgezeichnet worden.